UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025984
Receipt number R000029874
Scientific Title Evaluation of oxidative stress in patients with neuropsychiatric diseases using PET/MRI imaging
Date of disclosure of the study information 2017/02/03
Last modified on 2022/08/09 12:47:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of oxidative stress in patients with neuropsychiatric diseases using PET/MRI imaging

Acronym

Oxidative stress imaging in patients with neuropsychiatric diseases

Scientific Title

Evaluation of oxidative stress in patients with neuropsychiatric diseases using PET/MRI imaging

Scientific Title:Acronym

Oxidative stress imaging in patients with neuropsychiatric diseases

Region

Japan


Condition

Condition

Neuropsychiatric diseases

Classification by specialty

Neurology Psychiatry Radiology
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate oxidative stress in patients with neuropsychiatric diseases using 64Cu-ATSM PET/MRI imaging.

Basic objectives2

Others

Basic objectives -Others

Evaluation of the pathophysiology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate oxidative stress in patients with neuropsychiatric diseases using 64Cu-ATSM PET/MRI imaging.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine Device,equipment

Interventions/Control_1

PET/MRI, EEG, Neuropsychological tests

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with neuropsychiatric diseases
2. Healthy volunteers

Key exclusion criteria

Subjects that investigators and medical doctors need to exclude

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Masamichi
Middle name
Last name Ikawa

Organization

University of Fukui

Division name

Department of Neurology, University of Fukui Hospital

Zip code

910-1193

Address

23-3 Matsuoka-Shimoaiduki, Eiheiji, Fukui

TEL

0776-61-3111

Email

iqw@u-fukui.ac.jp


Public contact

Name of contact person

1st name Masamichi
Middle name
Last name Ikawa

Organization

University of Fukui

Division name

Department of Neurology, University of Fukui Hospital

Zip code

910-1193

Address

23-3 Matsuoka-Shimoaiduki, Eiheiji, Fukui

TEL

0776-61-3111

Homepage URL


Email

iqw@u-fukui.ac.jp


Sponsor or person

Institute

University of Fukui

Institute

Department

Personal name



Funding Source

Organization

JSPS

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Fukui

Address

23-3 Matsuoka-Shimoaiduki, Eiheiji, Fukui

Tel

0776-61-3111

Email

sm-kenkyusien@ml.u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 03 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

https://doi.org/10.3390/antiox11051022

Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2022 Year 05 Month 22 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 03 Day

Date of IRB

2017 Year 01 Month 23 Day

Anticipated trial start date

2017 Year 02 Month 03 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 03 Day

Last modified on

2022 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029874


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name